Measuring and Removing Genotoxic Impurities

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-05-15-2016, Volume 2016 eBook, Issue 2
Pages: s36-s39

Electrophilic and other reactive compounds, and their precursors, must be measured and removed to ensure patient safety.

Electrophilic and other reactive compounds, and their precursors, must be measured and removed to ensure patient safety.

Advertisement

Download

.

 

 

Related Content:

IngredientsQuality Assurance/Quality ControlQuality SystemsDevelopmentAPI Synthesis and Manufacturing, Small MoleculePharmaceutical Technology-05-15-2016
CordenPharma Leverages Peptide Drug Discovery and Development with GENEPEP and Works on Reducing Emissions
Susan Schniepp of Regulatory Compliance Associates Explores the Impact of QMS on Quality Maturity (INTERPHEX 2024)
Keynote Session Highlights Importance of Process Validation and Data Integrity (INTERPHEX 2024)